Abstract
References
Articles referenced by this article (14)
Barnett A, Iorio LC, Billard W (1986) Relationship of the behavioral effects of SCH 23390 and related benzazepines to their effects on dopamine1 (D1) receptors. In: Biggio G, Spano PF, Gessa GL (eds) Modulation of central and peripheral neurotransmitter function. Liviana Press, Padova, Italy, pp 15–25
Characterization of the binding of 3H-SCH 23390, a selective D-1 receptor antagonist ligand, in rat striatum.
Life Sci, (18):1885-1893 1984
MED: 6387355
[18F]setoperone: a new high-affinity ligand for positron emission tomography study of the serotonin-2 receptors in baboon brain in vivo.
Eur J Pharmacol, (1):73-82 1988
MED: 3259509
Pharmacological profile of SCH39166: a dopamine D1 selective benzonaphthazepine with potential antipsychotic activity.
J Pharmacol Exp Ther, (3):1093-1102 1988
MED: 2905002
PET analysis of human dopamine receptor subtypes using 11C-SCH 23390 and 11C-raclopride.
Psychopharmacology (Berl), (3):278-284 1987
MED: 2957716
Human dopamine receptor subtypes--in vitro binding analysis using 3H-SCH 23390 and 3H-raclopride.
J Neural Transm, (1):7-21 1988
MED: 2969950
Preparation of 11C-labelled SCH 23390 for the in vivo study of dopamine D-1 receptors using positron emission tomography.
Int J Rad Appl Instrum A, (10):1039-1043 1986
MED: 3027000
Halldin C, Farde L, Barnett A, Sedvall G (1990) Preparation of (11C)SCH 39166, a new selective D1-dopamine receptor ligand for PET. J Nucl Med 31:737
A preliminary evaluation of the Scanditronix PC2048-15B brain scanner.
Eur J Nucl Med, (11):719-721 1989
MED: 2583199
SCH 23390 - the first selective dopamine D-1 antagonist.
Eur J Pharmacol, (1):153-154 1983
MED: 6225651
Show 4 more references (10 of 14)
Citations & impact
Impact metrics
Citations of article over time
Smart citations by scite.ai
Explore citation contexts and check if this article has been
supported or disputed.
https://scite.ai/reports/10.1007/bf02244195
Article citations
Molecular Imaging of Opioid and Dopamine Systems: Insights Into the Pharmacogenetics of Opioid Use Disorders.
Front Psychiatry, 10:626, 18 Sep 2019
Cited by: 25 articles | PMID: 31620026 | PMCID: PMC6759955
Review Free full text in Europe PMC
Small Molecule Receptor Ligands for PET Studies of the Central Nervous System-Focus on G Protein Coupled Receptors.
Semin Nucl Med, 47(5):524-535, 06 Jul 2017
Cited by: 5 articles | PMID: 28826524
Review
Pharmacology of signaling induced by dopamine D(1)-like receptor activation.
Pharmacol Ther, 128(1):37-60, 12 Jun 2010
Cited by: 69 articles | PMID: 20547182 | PMCID: PMC2939266
Review Free full text in Europe PMC
Investigating the dopaminergic synapse in vivo. II. Molecular imaging studies in small laboratory animals.
Rev Neurosci, 18(6):473-504, 01 Jan 2007
Cited by: 10 articles | PMID: 18330213
Review
Probing cortical dopamine function in schizophrenia: what can D1 receptors tell us?
World Psychiatry, 2(3):166-171, 01 Oct 2003
Cited by: 26 articles | PMID: 16946930 | PMCID: PMC1525099
Go to all (24) article citations
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
PET examination of [11C]NNC 687 and [11C]NNC 756 as new radioligands for the D1-dopamine receptor.
Psychopharmacology (Berl), 113(2):149-156, 01 Jan 1993
Cited by: 91 articles | PMID: 7855175
[11C]NNC 22-0215, a metabolically stable dopamine D1 radioligand for PET.
Nucl Med Biol, 25(5):503-508, 01 Jul 1998
Cited by: 4 articles | PMID: 9720669
Carbon-11-NNC 112: a radioligand for PET examination of striatal and neocortical D1-dopamine receptors.
J Nucl Med, 39(12):2061-2068, 01 Dec 1998
Cited by: 53 articles | PMID: 9867142
Utilization of radioligands in schizophrenia research.
Clin Neurosci, 3(2):112-121, 01 Jan 1995
Cited by: 8 articles | PMID: 7583617
Review